VENUS REMEDIES Share Price

₹ 1,380.90

+₹65.70 (5.00%)
1D
Last updated 04 Nov, 2026, 15:27 IST
NSE: VENUSREM
|
Pharmaceuticals

VENUS REMEDIES Share Price Today

As of 4 Nov 2026, VENUS REMEDIES share price is ₹1,380.90. The stock opened at ₹1,316.10, compared to its previous close of ₹1,315.20. During today's trading session, VENUS REMEDIES share price moved in the range of ₹1,316.10 to ₹1,380.90, with an average price of ₹1,348.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹433.70 and a high of ₹2,044.30. On the performance front, VENUS REMEDIES share price has increased by 35.95% over the last six months and is up 196.32% on a year-on-year basis.

Share price over the last 1 day rose from 1316.10 to 1380.90, ranging between 1316.10 and 1380.90.
₹1,316.10
5.00% up today
₹1,380.90
1D LOW
1D HIGH

VENUS REMEDIES Stock Insights

Latest Earning
Op Profit TrendUp by 11.42% QoQ
Latest Earning
Net Profit TrendUp by 11.67% QoQ
Latest Earning
Revenue TrendUp by 20.82% QoQ
Stock Performance
OutperformingBeat Nifty by 38.02 % in last 6 month
Shareholding Pattern
DIIDII decreased stake by 16.36%
Shareholding Pattern
FIIFII increased stake by 7.44%
VENUS REMEDIES stock performance
Open₹1,316.10
High₹1,380.90
Low₹1,316.10
Prev. close₹1,315.20
VENUS REMEDIES trading activity
Volume35,894
Average traded price₹1,360.67
Last traded time03:27:42 04 Nov
Last traded quantity50
Circuit
L
H
₹1,249.50
₹1,380.90
52-week
L
H
₹433.70
₹2,044.30
Mkt Cap Cr
1,728.75
P/E
14.49
P/B
2.5
ROA
14.5%
ROE
17.27%
ROCE
22.14%
Quick Ratio
1.64
EV/EBITDA
9.18

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Venus Remedies has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Venus Remedies appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Venus Remedies revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,25,150.1638.74.769.61%13.79%18.65%2.3122.17
Divis Laboratories2,64,141.2491.0315.8914.6%15.32%19.56%3.559.98
Torrent Pharmaceuticals1,74,402.4784.09.64.7%11.42%11.37%0.7533.48
Laurus Labs1,26,811.2894.0820.6811.58%22.11%20.91%0.6853.48
Zydus Lifesciences1,23,685.4926.914.568.57%18.59%17.35%0.9116.36
Dr. Reddy's Laboratories1,14,351.2041.442.954.79%7.21%8.58%1.3518.91
Cipla1,11,647.7239.413.186.6%8.18%10.8%2.521.15
Mankind Pharma1,02,315.4045.25.827.82%12.76%14.68%0.7424.9
Aurobindo Pharma96,951.1826.352.586.34%9.25%11.76%1.1512.4
Lupin91,300.8316.574.114.47%23.76%24.88%1.429.76

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

VENUS REMEDIES Company Background

ISIN
INE411B01019
Sector Market Cap
₹ 1,728.75 Cr

Venus Remedies Limited is a research-driven pharmaceutical company. The Company is a global injectable manufacturer. It manufactures products catering to critical care segments such as antimicrobial resistance, anti-cancer, Anti-infective, Neurology, Skin and Wound Care, and Pain Management. With a diverse portfolio of products, the Company is dedicated to revolutionizing patient care through its specialized therapeutic segments such as anti-infective (antibiotics), oncology, neurology, pain management, and skin & wound care. The Company operates only in one business segment: Pharmaceutical Formulation and is engaged in manufacturing and trading of medicines. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, and others. It has three manufacturing facilities: Panchkula and Baddi in India and Werne in Germany.

VENUS REMEDIES Financial Highlights

  • Revenue: VENUS REMEDIES reported revenue of ₹782.18 crore in FY26 vs ₹668.84 crore in FY25. It showed an increase of 16.95% on a yearly basis.
  • Operating Profit: VENUS REMEDIES reported an operating profit of ₹134.16 crore in FY26 vs ₹71.82 crore in FY25. It showed an increase of 86.80% on a year-on-year basis.
  • Net Profit: VENUS REMEDIES reported a net profit of ₹102.79 crore in FY26 vs ₹45.32 crore in FY25. It showed an increase of 126.81% on a yearly basis.

VENUS REMEDIES Quarterly Result Highlights

  • VENUS REMEDIES reported revenue of ₹219.27 crore in Sep 2026, compared with ₹181.48 crore in Jun 2026, representing an increase of 20.82% on a quarter-on-quarter (QoQ) basis.
  • VENUS REMEDIES reported an operating profit of ₹33.47 crore in Sep 2026, compared with ₹30.04 crore in Jun 2026, representing an increase of 11.42% on a quarter-on-quarter (QoQ) basis.
  • VENUS REMEDIES reported a profit of ₹25.65 crore in Sep 2026, compared with ₹22.97 crore in Jun 2026, reflecting an increase of 11.67% on a QoQ basis.
  • The earnings per share (EPS) of VENUS REMEDIES stood at ₹33.90 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
41.76%
FII
3.14%
Other DII
0.74%
Retail and other
54.36%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20252.26%
Mar 20262.80%
Jun 20262.92%
Sep 20263.14%

VENUS REMEDIES Investment Returns

1 day
+1.13%
1 week
-5.30%
1 month
-26.80%
1 year
+196.32%
3 years
+399.13%
5 years
+150.32%

VENUS REMEDIES Share Price History

VENUS REMEDIES share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹1,357.90 / ₹1,315.20
+1.13%
02 Nov 26
₹1,235.00 / ₹1,300.50
+5.00%
30 Oct 26
₹1,290.00 / ₹1,238.60
-3.93%
29 Oct 26
₹1,315.10 / ₹1,289.30
-3.07%
Show more

VENUS REMEDIES Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹647.89₹601.45₹555.51₹600.18
Other Income₹20.96₹11.58₹10.32₹8.31
Total Revenue₹668.84₹613.03₹565.83₹608.49
Total Expenses₹606.93₹568.39₹527.90₹572.08
Profit Before Tax₹71.83₹44.64₹37.93₹36.41
Tax₹26.51₹16.15₹11.36-₹4.32
Profit After Tax₹45.31₹28.49₹26.57₹40.72
EPS - Basic₹33.90₹21.31₹19.88₹30.86
EPS - Diluted₹33.90₹21.31₹19.88₹30.86

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹134.15₹61.87₹44.64₹37.93
Income before WC changes₹152.52₹78.95₹64.88₹61.26
Change in Assets-₹22.08₹8.79-₹45.64-₹86.18
Change in Liabilities₹59.59₹13.62₹33.53₹61.55
Change in WC₹37.52₹22.42-₹12.11-₹24.63
Cash flow from Operations₹155.77₹86.44₹37.29₹36.63
Cash flow from Investing-₹181.57-₹76.25-₹7.21-₹50.83
Cash flow from Financing-₹3.12-₹1.02-₹1.08-₹0.57
Total Cash Flow-₹28.91₹9.18₹28.99-₹14.77
Cash (Start of the year)₹57.52₹48.96₹21.21₹43.26
Cash (End of the year)₹25.12₹57.52₹48.96₹21.21

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹264.00₹267.30₹278.25₹301.78
Current Assets₹451.72₹359.52₹322.84₹278.04
Total Assets₹715.72₹626.82₹601.08₹579.82
Current Liabilities₹136.29₹79.42₹82.57₹92.74
Net Current Asset₹315.43₹280.11₹240.26₹185.30
Non-Current Liabilities₹18.48₹59.86₹58.17₹46.63
Equity Capital₹560.95₹487.55₹460.34₹440.45
Total Equity & Liabilities₹715.72₹626.82₹601.08₹579.82

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹639.46₹575.21₹537.66₹576.71
Other Income₹20.78₹11.32₹10.17₹8.43
Total Revenue₹660.24₹586.53₹547.84₹585.14
Total Expenses₹591.08₹539.88₹507.51₹540.47
Profit Before Tax₹79.08₹46.65₹40.33₹44.67
Tax₹26.51₹16.15₹11.36-₹4.32
Profit After Tax₹52.56₹30.50₹28.96₹48.99
EPS - Basic₹39.32₹22.82₹21.67₹37.12
EPS - Diluted₹39.32₹22.82₹21.67₹37.12

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹130.67₹69.16₹46.65₹40.33
Income before WC changes₹148.03₹85.28₹66.01₹62.58
Change in Assets-₹15.75-₹7.85-₹16.70-₹24.98
Change in Liabilities₹53.08₹20.59₹1.56-₹9.55
Change in WC₹37.33₹12.74-₹15.15-₹34.53
Cash flow from Operations₹151.09₹83.10₹35.38₹28.05
Cash flow from Investing-₹181.57-₹76.20-₹6.94-₹50.81
Cash flow from Financing-₹1.39₹0.00₹0.00₹0.00
Total Cash Flow-₹31.86₹6.90₹28.44-₹22.76
Cash (Start of the year)₹55.41₹48.51₹20.07₹42.83
Cash (End of the year)₹23.54₹55.41₹48.51₹20.07

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹277.46₹280.26₹290.70₹314.25
Current Assets₹435.75₹361.00₹318.19₹264.41
Total Assets₹713.21₹641.26₹608.89₹578.66
Current Liabilities₹105.23₹72.81₹72.67₹82.61
Net Current Asset₹330.51₹288.18₹245.53₹181.80
Non-Current Liabilities₹18.48₹59.86₹58.17₹46.63
Equity Capital₹589.49₹508.59₹478.05₹449.41
Total Equity & Liabilities₹713.21₹641.26₹608.89₹578.66
* All values are in INR Crore
VENUS REMEDIES market depth
Bid quantityBid priceAsk priceAsk quantity
5001380.900
0000
0000
0000
0000
Total bid quantity500
Total ask quantity0
VENUS REMEDIES technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
34.93
Neutral
ATR (14)
79.74
Neutral
STOCH(9,6)
31.39
Neutral
STOCH RSI (14)
35.67
Neutral
ADX(9)
33.7
Bearish
UO(9)
37.77
Neutral
ROC(12)
-16.35
Bearish
WillR(14)
-77.76
Neutral
Period
Simple value
Exponential vaue
5D
1294.76
1316.75
10D
1368.4
1372.02
20D
1504.37
1457.32
50D
1590.67
1548.29
100D
1653.85
1520.44
Volume trend — traded volume by day
4 Nov0L
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct1L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

VENUS REMEDIES
Pharmaceuticals
Add Stock
Add Another

VENUS REMEDIES Share Price FAQs

Please be aware that VENUS REMEDIES stock prices are subject to continuous fluctuations due to various factors.